Canada Infectious Disease Therapeutics Market Analysis

Canada Infectious Disease Therapeutics Market Analysis


$ 3999

Canada's infectious disease therapeutics market is likely to grow at a CAGR of 4.35% from a market size of $9.59 Bn in 2022 to $13.48 Bn in 2030. The increase in the prevalence of infectious diseases in Canada and the increasing government initiatives to provide facilities to patients have acted as a market growth driver. This report is segmented by mode of treatment, applications, disease type, target organisms, and end user. Some key players in this market include Novartis, Roche, Janssen Pharmaceutical, Merck, BI, and others.

ID: IN10CAPH038 CATEGORY: Pharmaceuticals GEOGRAPHY: Canada AUTHOR: Dhruv Joshi

Buy Now

Canada Infectious Disease Therapeutics Market Executive Summary

Canada's infectious disease therapeutics market size is at around $9.59 Bn in 2022 and is projected to reach $13.48 Bn in 2030, exhibiting a CAGR of 4.35% during the forecast period 2022-2030. Canada is the western hemisphere's largest country and one of the world's largest. It has a vibrant free-market economy, with businesses ranging from small owner-managed enterprises to multinational companies. Historically, Canada's economy was built on the export of agricultural staples, particularly grain, as well as the manufacture and sale of natural resource exports including minerals, oil and gas, and forest products.

The total number of medicine purchases in Canada is anticipated to increase. The outpatient sector is predicted to continue seeing moderate levels of growth in drug spending (3% to 4%), whereas hospital settings are predicted to see higher rates of growth (7% to 8%). Around 307,205 deaths have been occurred in 2020 due to infectious diseases in Canada. Out of all these deaths, 96 deaths were due to Tuberculosis, 135 were due to HIV, and 94 deaths were due to viral infections of the central nervous system. Emerging infectious diseases (EIDs), including West Nile virus, severe acute respiratory syndrome (SARS), and Lyme disease, have had a direct effect within Canada, while many more EIDs such as Zika, chikungunya, and Ebola are a threat to Canadians while traveling.

canada infectious disease therapeutics market analysis

Market Dynamics

Market Growth Drivers

A significant possibility for the market's expansion is the enormous population of individuals who fall under the genetic category. The increase in the average person's discretionary income has also become a significant potential. Those with high disposable incomes can choose to receive cutting-edge medical care, which supports the market's expansion. The rising incidence of infectious diseases in society has been identified as a key driver of the therapeutic system's expansion. To increase earnings, major market companies have introduced cutting-edge drugs to treat infectious diseases. The government has taken steps to provide citizens with cutting-edge facilities for the treatment of infectious diseases. The development of new drugs for the treatment of infectious diseases also acts as a growth driver for the Canada infectious disease therapeutics market.

Market Restraints

The lack of skilled professionals treating infectious disease patients hampers the market growth. There is a high cost of treatment of infectious diseases which also acts as a burden to the patients hence affecting the market growth. The lack of trained workers in the industry, which significantly restrains the market's growth, is a major problem for the infectious disease therapeutics market. The market's rising demand for generic medications has put pressure on the growth of branded medications for infectious disorders.

Competitive Landscape

Key Players

  • Novartis
  • Roche
  • Janssen Pharmaceutlcal
  • Merck
  • Boehringer Ingelheim
  • Sanofi
  • AstraZeneca     
  • GlaxoSmithKline

Healthcare Policies and Regulatory Landscape

The federal health portfolio includes the Public Health Agency of Canada. Its efforts are centered on preventing illness and injury, addressing threats to public health, promoting excellent physical and mental health, and disseminating knowledge to assist in making informed decisions. Access to safe and effective medicines and healthcare items is actively protected by Health Canada. The Department makes an effort to balance the risks and benefits to health that each medicine and medical product may have. Public safety is given top importance when deciding how to strike a balance. The department strives to reduce the health risks to you and increase the safety offered by the regulatory system for these items by collaborating with other levels of government, healthcare professionals, patient and consumer interest groups, research communities, and manufacturers.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Infectious Disease Therapeutics Segmentation

By Mode of Treatment (Revenue, USD Billion):

  • Vaccines
  • Drugs

By Applications (Revenue, USD Billion):

  • HIV/AIDS
  • Influenza
  • Hepatitis
  • Malaria
  • Tuberculosis
  • Others

By Disease Type (Revenue, USD Billion):

  • Viral Diseases
  • Bacterial Diseases
  • Fungal Diseases
  • Parasitic Diseases
  • Others

By Target Organism (Revenue, USD Billion):

  • Antibiotics
  • Antivirals
  • Antifungals
  • Anti-Parasitic
  • Others

By End User (Revenue, USD Billion):

  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 05 December 2023
Updated by: Jay Dalwadi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up